Equities analysts predict that The Beauty Health Company (NASDAQ:SKIN – Get Rating) will report sales of $69.47 million for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Beauty Health’s earnings, with the lowest sales estimate coming in at $65.90 million and the highest estimate coming in at $73.17 million. The firm is expected to report its next earnings results after the market closes on Monday, January 1st.
According to Zacks, analysts expect that Beauty Health will report full-year sales of $329.24 million for the current fiscal year, with estimates ranging from $325.30 million to $336.20 million. For the next year, analysts forecast that the business will post sales of $411.27 million, with estimates ranging from $396.80 million to $429.30 million. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Beauty Health.
Beauty Health (NASDAQ:SKIN – Get Rating) last posted its quarterly earnings results on Tuesday, February 22nd. The company reported $0.01 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.03) by $0.04. The firm had revenue of $77.90 million during the quarter, compared to analyst estimates of $70.90 million. The company’s revenue for the quarter was up 106.1% compared to the same quarter last year.
SKIN has been the topic of several recent analyst reports. Benchmark boosted their target price on Beauty Health from $18.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, March 14th. Piper Sandler lowered their price objective on shares of Beauty Health from $31.00 to $26.00 in a research report on Thursday, April 28th. William Blair started coverage on shares of Beauty Health in a report on Friday, January 7th. They set an “outperform” rating on the stock. JPMorgan Chase & Co. assumed coverage on shares of Beauty Health in a report on Friday, March 11th. They set an “overweight” rating and a $24.00 price target on the stock. Finally, Zacks Investment Research upgraded shares of Beauty Health from a “hold” rating to a “buy” rating and set a $21.00 price objective for the company in a report on Saturday, February 26th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, Beauty Health currently has a consensus rating of “Buy” and a consensus target price of $27.20.
Several large investors have recently modified their holdings of SKIN. Nisa Investment Advisors LLC bought a new position in shares of Beauty Health in the 4th quarter valued at about $47,000. PNC Financial Services Group Inc. raised its position in shares of Beauty Health by 47.5% in the 3rd quarter. PNC Financial Services Group Inc. now owns 1,962 shares of the company’s stock valued at $50,000 after buying an additional 632 shares in the last quarter. Lindbrook Capital LLC acquired a new position in shares of Beauty Health in the 4th quarter valued at approximately $74,000. Logan Capital Management Inc. acquired a new position in Beauty Health during the 3rd quarter worth approximately $78,000. Finally, First Mercantile Trust Co. acquired a new position in Beauty Health during the 3rd quarter worth approximately $82,000. Institutional investors and hedge funds own 72.01% of the company’s stock.
Shares of NASDAQ SKIN opened at $13.76 on Tuesday. The company has a current ratio of 13.09, a quick ratio of 12.63 and a debt-to-equity ratio of 2.41. The stock has a 50 day simple moving average of $16.55 and a 200-day simple moving average of $19.81. Beauty Health has a 12-month low of $11.12 and a 12-month high of $30.17.
Beauty Health Company Profile (Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Beauty Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Beauty Health and related companies with MarketBeat.com’s FREE daily email newsletter.